Reckitt’s VMS sales fall despite Neuriva rise

28 July 2021 - Deborah Wilkes


Worldwide sales of Reckitt’s vitamins, minerals and supplements (VMS) portfolio fell by 15% in the first half of 2021 as Neuriva recorded “exceptionally strong growth” but Airborne struggled in the “weak cold and flu season”.

Click tags below for more information on topics:

Reckitt COVID-19

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: